Covid-19 vaccine will not kill Africans – Akufo-Addo assures

The President of Ghana, Nana Akufo-Addo, has indicated that AstraZeneca coronavirus vaccine to be deployed in Ghana and other African nations is safe for use.

Mr. Akufo-Addo says contrary to widely held claims that the vaccines were intended to kill Africans and cause diseases, they are actually safe for human use.

He says for instance, the Food and Drugs Authority (FDA) of Ghana has approved the AstraZeneca coronavirus vaccine after due diligence and are deemed safe.

Mr Akufo-Addo made this known in his 24th Covid19 update to the nation on Sunday night, February 28, 2021.

His address delivered from the Jubilee House, the seat of Governance in the national capital, Accra, came as Ghana prepares to deploy the 600,000 doses of the AstraZeneca coronavirus vaccine from March 2, 2021.

Mr Akufo-Addo touched on the doubt by expressed by some people concerning the vaccine and its efficacy.

According to him,  no vaccine will be deployed in the country for use without the expressed certification of the FDA.

Taking the vaccine will not cause infertility in men or vaccine, he said.

Mr Akufo-Addo stressed that the vaccine is safe and that is why he and his wife, Vice President Bawumia and his wife will take the vaccine publicly.

Deployment Plan

He disclosed that the Coronavirus vaccines will be administered across the 43 epicenter districts in Ghana.

He explained that 25 of the districts are in the Greater Accra Region.

According to him, 16 of the districts are in the Ashanti Region and two in the Central Region.

Deaths

Meanwhile,  he revealed that since his last Coronavirus update to the nation, some 191 people have died from the virus in the country.

According to him, since his update no.23 about a month ago, Coronavirus deaths in Ghana have risen to 607 as of Friday, February 27, 2021.

Mr. Akufo-Addo noted thay daily infections rate was about 400.

He said Covid19 cases have been recorded in 207 schools.

Leave a Reply

Your email address will not be published. Required fields are marked *